Clinical Trial for Advanced Bile Duct Cancer
0 Visualizzazioni
• 07/01/23
0
0
Incorporare
administrator
Iscritti
Learn about a phase II multi-center study evaluating combination immunotherapy for advanced cholangiocarcinoma (bile duct cancer) with pembrolizumab and Sylatron (peginterferon alfa-2b): HCRN GI16-263. https://hoosiercancer.org/clin....ical-trials/trial/gi
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti